BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21763285)

  • 1. Biochemical characterization of nuclear receptors for vitamin D3 and glucocorticoids in prostate stroma cell microenvironment.
    Hidalgo AA; Montecinos VP; Paredes R; Godoy AS; McNerney EM; Tovar H; Pantoja D; Johnson C; Trump D; Onate SA
    Biochem Biophys Res Commun; 2011 Aug; 412(1):13-9. PubMed ID: 21763285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered VDR-mediated transcriptional activity in prostate cancer stroma.
    Hidalgo AA; Paredes R; Garcia VM; Flynn G; Johnson CS; Trump DL; Onate SA
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):731-6. PubMed ID: 17368189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk between the peroxisome proliferator-activated receptor γ (PPARγ) and the vitamin D receptor (VDR) in human breast cancer cells: PPARγ binds to VDR and inhibits 1α,25-dihydroxyvitamin D3 mediated transactivation.
    Alimirah F; Peng X; Yuan L; Mehta RR; von Knethen A; Choubey D; Mehta RG
    Exp Cell Res; 2012 Nov; 318(19):2490-7. PubMed ID: 22884583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention.
    Bartik L; Whitfield GK; Kaczmarska M; Lowmiller CL; Moffet EW; Furmick JK; Hernandez Z; Haussler CA; Haussler MR; Jurutka PW
    J Nutr Biochem; 2010 Dec; 21(12):1153-61. PubMed ID: 20153625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to 1,25D-induced differentiation in human acute myeloid leukemia HL60-40AF cells is associated with reduced transcriptional activity and nuclear localization of the vitamin D receptor.
    Garay E; Donnelly R; Wang X; Studzinski GP
    J Cell Physiol; 2007 Dec; 213(3):816-25. PubMed ID: 17520689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VDR activity is differentially affected by Hic-5 in prostate cancer and stromal cells.
    Solomon JD; Heitzer MD; Liu TT; Beumer JH; Parise RA; Normolle DP; Leach DA; Buchanan G; DeFranco DB
    Mol Cancer Res; 2014 Aug; 12(8):1166-80. PubMed ID: 24825850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recruitment of NCOR1 to VDR target genes is enhanced in prostate cancer cells and associates with altered DNA methylation patterns.
    Doig CL; Singh PK; Dhiman VK; Thorne JL; Battaglia S; Sobolewski M; Maguire O; O'Neill LP; Turner BM; McCabe CJ; Smiraglia DJ; Campbell MJ
    Carcinogenesis; 2013 Feb; 34(2):248-56. PubMed ID: 23087083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prostate cancer TMPRSS2:ERG fusion synergizes with the vitamin D receptor (VDR) to induce CYP24A1 expression-limiting VDR signaling.
    Kim JS; Roberts JM; Bingman WE; Shao L; Wang J; Ittmann MM; Weigel NL
    Endocrinology; 2014 Sep; 155(9):3262-73. PubMed ID: 24926821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone enhances 1alpha,25-dihydroxyvitamin D3 effects by increasing vitamin D receptor transcription.
    Hidalgo AA; Deeb KK; Pike JW; Johnson CS; Trump DL
    J Biol Chem; 2011 Oct; 286(42):36228-37. PubMed ID: 21868377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-6 Impairs the Activity of Vitamin D3 in the Regulation of Epithelial-Mesenchymal Transition in Triple Negative Breast Cancer.
    Abdel-Mohsen MA; Abo Deif SM; Abou-Shamaa LA
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2267-2273. PubMed ID: 31450894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S; Shevde NK; Pike JW
    J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription.
    Lu X; Farmer P; Rubin J; Nanes MS
    J Cell Biochem; 2004 Jul; 92(4):833-48. PubMed ID: 15211579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
    Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
    Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D receptor content and transcriptional activity do not fully predict antiproliferative effects of vitamin D in human prostate cancer cell lines.
    Zhuang SH; Schwartz GG; Cameron D; Burnstein KL
    Mol Cell Endocrinol; 1997 Jan; 126(1):83-90. PubMed ID: 9027366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel regulation of 25-hydroxyvitamin D3 24-hydroxylase (24(OH)ase) transcription by glucocorticoids: cooperative effects of the glucocorticoid receptor, C/EBP beta, and the Vitamin D receptor in 24(OH)ase transcription.
    Dhawan P; Christakos S
    J Cell Biochem; 2010 Aug; 110(6):1314-23. PubMed ID: 20564225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression and regulation of vitamin D hydroxylases and inflammatory genes in prostate stroma and epithelium by 1,25-dihydroxyvitamin D in men with prostate cancer and an in vitro model.
    Giangreco AA; Dambal S; Wagner D; Van der Kwast T; Vieth R; Prins GS; Nonn L
    J Steroid Biochem Mol Biol; 2015 Apr; 148():156-65. PubMed ID: 25305352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel vitamin D receptor interacting proteins that modulate 1,25-dihydroxyvitamin D3 signaling.
    Marshall PA; Hernandez Z; Kaneko I; Widener T; Tabacaru C; Aguayo I; Jurutka PW
    J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):147-59. PubMed ID: 22626544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate derived factor in human prostate cancer cells: gene induction by vitamin D via a p53-dependent mechanism and inhibition of prostate cancer cell growth.
    Lambert JR; Kelly JA; Shim M; Huffer WE; Nordeen SK; Baek SJ; Eling TE; Lucia MS
    J Cell Physiol; 2006 Sep; 208(3):566-74. PubMed ID: 16741990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LSD1 dual function in mediating epigenetic corruption of the vitamin D signaling in prostate cancer.
    Battaglia S; Karasik E; Gillard B; Williams J; Winchester T; Moser MT; Smiraglia DJ; Foster BA
    Clin Epigenetics; 2017; 9():82. PubMed ID: 28811844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cellular environment on the selective activation of the vitamin D receptor by 1alpha,25-dihydroxyvitamin D3 and its analog 1alpha-fluoro-16-ene-20-epi-23-ene-26,27-bishomo-25-hydroxyvitamin D3 (Ro-26-9228).
    Ismail A; Nguyen CV; Ahene A; Fleet JC; Uskokovic MR; Peleg S
    Mol Endocrinol; 2004 Apr; 18(4):874-87. PubMed ID: 14726489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.